Demant A/S
CSE:DEMANT
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
249.4
371
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DEMANT stock under the Base Case scenario is 358.07 DKK. Compared to the current market price of 266.2 DKK, Demant A/S is Undervalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Demant A/S
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DEMANT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Demant A/S
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Demant A/S is a leading global player in the audiology and communication technology sectors, renowned for its innovative solutions that enhance the quality of life for individuals with hearing and communication challenges. Founded in Denmark over a century ago, the company has grown from its initial focus on hearing aids to a comprehensive portfolio that includes audiometric equipment, personal communication, and advanced technologies that cater to both consumers and professionals. With a commitment to research and development, Demant continuously pioneers new products and solutions, making it a trusted name among healthcare professionals and users alike. As the demand for hearing solutions...
Demant A/S is a leading global player in the audiology and communication technology sectors, renowned for its innovative solutions that enhance the quality of life for individuals with hearing and communication challenges. Founded in Denmark over a century ago, the company has grown from its initial focus on hearing aids to a comprehensive portfolio that includes audiometric equipment, personal communication, and advanced technologies that cater to both consumers and professionals. With a commitment to research and development, Demant continuously pioneers new products and solutions, making it a trusted name among healthcare professionals and users alike.
As the demand for hearing solutions continues to rise due to an aging population and increasing awareness of hearing health, Demant is well-positioned to capitalize on these trends. The company's global footprint and strategic partnerships across various markets play a crucial role in driving its growth trajectory. By leveraging advanced technology and a commitment to customer satisfaction, Demant not only enhances its competitive edge but also contributes positively to its financial performance. For investors, Demant A/S represents a unique opportunity to engage with a forward-thinking company that is dedicated to making a difference in people's lives while promising robust returns in a growing sector.
Demant A/S is a Danish company primarily known for its development and manufacturing of hearing aids and related products, but it operates across several core business segments. Here’s an overview of its main business areas:
-
Hearing Aids: This is the core segment of Demant's business. The company designs and produces hearing aids that cater to various levels of hearing impairment. They focus on innovative technology, including smart features, enhanced sound quality, and connectivity options (like Bluetooth).
-
Audiometric Equipment: Demant produces a range of audiometric equipment, which is used for hearing tests and assessments. This includes audiometers, tympanometers, and software solutions that help audiologists evaluate hearing abilities.
-
Personal Communication: This segment focuses on solutions that enhance communication for individuals with hearing impairments. This includes accessories that improve the use of hearing aids in various situations, such as phone calls and public speaking.
-
Otological Surgical Equipment: Demant is involved in the development and supply of surgical equipment used in ear surgeries, such as those for cochlear implants. This segment highlights the company's role in providing comprehensive solutions for hearing impairment.
-
Consumer Sound Solutions: This area includes products designed to enhance sound experiences for consumers, such as products that improve sound quality for music and speech in everyday life.
-
Digital Solutions: Demant is increasingly focusing on digital health services and solutions, leveraging telehealth and remote support capabilities to provide ongoing care and product management for users.
-
Retail and Distribution: Through its various brands and partnerships, Demant also engages in the retail and distribution of hearing aids and related products, ensuring accessibility to its customers.
By operating across these segments, Demant A/S positions itself as a leader in the hearing healthcare industry, leveraging advanced technology and comprehensive solutions to meet the needs of individuals with hearing impairments.
Demant A/S, a leading company in the hearing aid and audiological equipment market, has several unique competitive advantages that distinguish it from its rivals:
-
Strong Brand Reputation: Demant has established a strong brand reputation built on decades of experience and innovation in hearing solutions. This trust with consumers and healthcare professionals enhances customer loyalty and preference.
-
Innovative Product Development: The company invests significantly in research and development, leading to a robust product pipeline. Innovations such as advanced sound processing, connectivity features (like Bluetooth), and user-friendly designs help maintain a competitive edge.
-
Comprehensive Product Range: Demant offers a wide array of products beyond hearing aids, including audiometric equipment, personal communication solutions, and related health services. This diversification allows for cross-selling opportunities and reduces reliance on a single product category.
-
Strong Distribution Networks: The company has developed strong relationships with audiologists, healthcare professionals, and distributors globally, facilitating effective market penetration and customer reach.
-
Focus on Consumer Experience: Demant invests in user-friendly designs and features that enhance the overall consumer experience. Products are often designed with adaptability and customization in mind, catering to varying user needs and preferences.
-
Technological Integration: The incorporation of cutting-edge technology, including digital enhancements and AI, allows for advanced functionalities, such as automatic adjustments and personalized hearing profiles, setting Demant apart from competitors.
-
Commitment to Accessibility: Demant actively participates in initiatives promoting hearing health awareness and accessibility, which enhances its corporate social responsibility profile and strengthens its brand image.
-
Strong Financial Position: A solid financial foundation provides the company with the resources to invest in growth, enter new markets, or enhance its research and development efforts, ensuring long-term competitiveness.
-
Global Reach with Local Expertise: Demant operates in numerous countries, allowing it to leverage local market insights and adapt its strategies to meet regional demands effectively.
By capitalizing on these unique competitive advantages, Demant A/S positions itself as a leader in the hearing technology space, better equipped to face industry challenges and capitalize on growth opportunities.
Demant A/S, a global leader in the hearing aid and audiology market, faces several risks and challenges in the near future. Here are key considerations:
-
Market Competition: The audiology market is becoming increasingly competitive, with numerous players offering innovative products. Competitors may introduce lower-priced alternatives or advanced technologies, which could erode Demant’s market share.
-
Technological Advancements: Rapid technological changes require continuous investment in R&D. If Demant fails to keep pace with innovations, especially in areas like connected devices and AI in hearing solutions, it may struggle to meet consumer expectations.
-
Regulatory Changes: The healthcare industry, particularly in hearing aids, is subject to strict regulations. Changes in regulations, especially in different markets, could affect product approvals, manufacturing processes, and overall market access.
-
Supply Chain Disruptions: Supply chain challenges, exacerbated by global events (such as pandemics or geopolitical tensions), can impact production and distribution capabilities, leading to increased costs and delayed product launches.
-
Economic Conditions: Economic downturns can lead to reduced consumer spending on non-essential health products, including hearing aids. Affordability and insurance coverage issues could also influence overall market demand.
-
Changing Consumer Behavior: As consumer preferences evolve towards more technologically advanced, integrated health solutions, Demant must adapt its offerings. Failure to understand and respond to these changes could result in lost market opportunities.
-
Dependency on Key Markets: A significant portion of Demant's revenue may come from specific geographic markets. Economic or political instability in these areas could present risks to sales and profit margins.
-
Healthcare System Transformation: The shift toward value-based healthcare and consumer-driven models may influence how hearing aids are marketed and sold, necessitating adjustments to business strategies.
-
Talent Acquisition and Retention: Attracting and retaining skilled professionals in a competitive job market is crucial for innovation and growth. Labor shortages or turnover can impact operational efficiency.
-
Cybersecurity Risks: As Demant continues to innovate digitally and integrate IoT technologies into its products, it becomes more exposed to cybersecurity threats that could compromise sensitive consumer data or disrupt operations.
Addressing these risks and adapting to challenges will be essential for Demant A/S to maintain its competitive position and harness growth opportunities in the evolving market landscape.
Revenue & Expenses Breakdown
Demant A/S
Balance Sheet Decomposition
Demant A/S
Current Assets | 10.7B |
Cash & Short-Term Investments | 1B |
Receivables | 4.6B |
Other Current Assets | 5B |
Non-Current Assets | 21.7B |
Long-Term Investments | 559m |
PP&E | 5.5B |
Intangibles | 14.5B |
Other Non-Current Assets | 1.2B |
Current Liabilities | 7.5B |
Accounts Payable | 858m |
Other Current Liabilities | 6.6B |
Non-Current Liabilities | 15.5B |
Long-Term Debt | 13.2B |
Other Non-Current Liabilities | 2.3B |
Earnings Waterfall
Demant A/S
Revenue
|
22.4B
DKK
|
Cost of Revenue
|
-5.5B
DKK
|
Gross Profit
|
16.9B
DKK
|
Operating Expenses
|
-12.7B
DKK
|
Operating Income
|
4.2B
DKK
|
Other Expenses
|
-1.7B
DKK
|
Net Income
|
2.4B
DKK
|
Free Cash Flow Analysis
Demant A/S
DKK | |
Free Cash Flow | DKK |
In the first half of the year, the company witnessed a strong surge, with organic growth of 13% and EBIT soaring to a record high of nearly DKK 2 billion, representing a stellar 27% growth. The group's margin improved by 1.4 percentage points, benefiting from significant operating leverage in the Hearing Healthcare business, where a robust cash flow of DKK 1.8 billion was also observed. These outstanding figures led to an optimistic revision of the full year outlook, with organic growth expectations elevated from 6-10% to 11-14%, and EBIT forecasts raised from DKK 3.8-4.2 billion to DKK 4-4.4 billion. Despite adverse exchange rates causing a 1.3% decline in gross margins, the company experienced elevated demand across its Hearing Care and Diagnostics segments, countered by a disappointing performance in the Communication sector. Sustainability milestones are equally noteworthy, with the approval of science-based CO2e emissions reduction targets, a renewable energy share hitting 22%, and increases in gender diversity enriching management across the board.
What is Earnings Call?
DEMANT Profitability Score
Profitability Due Diligence
Demant A/S's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Demant A/S's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
DEMANT Solvency Score
Solvency Due Diligence
Demant A/S's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Demant A/S's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DEMANT Price Targets Summary
Demant A/S
According to Wall Street analysts, the average 1-year price target for DEMANT is 305.89 DKK with a low forecast of 247.45 DKK and a high forecast of 378 DKK.
Dividends
Current shareholder yield for DEMANT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Demant A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The firm operates globally, through more than 90 subsidiaries and associates worldwide.
Officers
The intrinsic value of one DEMANT stock under the Base Case scenario is 358.07 DKK.
Compared to the current market price of 266.2 DKK, Demant A/S is Undervalued by 26%.